CytRx Corporation (CYTR): Price and Financial Metrics
CytRx Corporation (CYTR)
Today's Latest Price: $0.72 USD
0.02 (-2.04%)
Updated Nov 27 8:28pm
Add CYTR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CYTR Stock Summary
- Of note is the ratio of Cytrx Corp's sales and general administrative expense to its total operating expenses; 99.26% of US stocks have a lower such ratio.
- For CYTR, its debt to operating expenses ratio is greater than that reported by only 0.39% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Cytrx Corp's debt growth rate surpasses just 0% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Cytrx Corp, a group of peers worth examining would be LOV, AMSC, AKRX, IPWR, and REGI.
- CYTR's SEC filings can be seen here. And to visit Cytrx Corp's official web site, go to www.cytrx.com.
CYTR Stock Price Chart Interactive Chart >
CYTR Price/Volume Stats
| Current price | $0.72 | 52-week high | $0.85 |
| Prev. close | $0.74 | 52-week low | $0.23 |
| Day low | $0.70 | Volume | 39,000 |
| Day high | $0.75 | Avg. volume | 125,030 |
| 50-day MA | $0.60 | Dividend yield | N/A |
| 200-day MA | $0.59 | Market Cap | 26.27M |
CytRx Corporation (CYTR) Company Bio
CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company was founded in 1985 and is based in Los Angeles, California.
Loading social stream, please wait...